Biofourmis to grow data platform with General Atlantic-led $300M series D

Virtual care company Biofourmis will use the $300 million it raised in a series D round this week to develop and deploy its remote patient monitoring platform in collaboration with hospitals, pharma and payers. Specific use cases include the post-infusion monitoring of cancer patients and clinical trials. 

The company, which announced the round Wednesday, also said former Medtronic CEO and Intel Chairperson Omar Ishrak will chair its board...